Anzeige
Mehr »
Sonntag, 07.06.2026 - Börsentäglich über 12.000 News
Breaking News: Nasdaq Quantencomputer Play mit riesigem Kurspotential!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 938282 | ISIN: FR0004050250 | Ticker-Symbol: NE9
Stuttgart
05.06.26 | 21:56
38,050 Euro
0,00 % 0,000
Branche
IT-Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEURONES SA Chart 1 Jahr
5-Tage-Chart
NEURONES SA 5-Tage-Chart
RealtimeGeldBriefZeit
37,50037,90006.06.

Aktuelle News zur NEURONES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoNEURONES: Description of the share buyback program2
MoNEURONES: Declaration of transactions on treasury shares (May 25 to 29, 2026)1
26.05.NEURONES: Declaration of transactions on treasury shares (May 18 to 22, 2026)1
18.05.NEURONES: Declaration of transactions on treasury shares (May 11 to 15, 2026)1
11.05.NEURONES: Declaration of transactions on treasury shares (May 4 to 8, 2026)1
06.05.NEURONES: + 5.6% organic growth in Q1 2026324PRESS INFORMATIONHeading: 1st quarter 2026 revenues Nanterre, May 6, 2026 (after trading) + 5.6% organic growth in Q1 2026 (in millions of euros)Q1 2025Q1 2026Growthof which organicRevenues214.1227.7+...
► Artikel lesen
27.04.NEURONES: Declaration of transactions on treasury shares (April 20 to 24, 2026)262Nanterre, April 27, 2026 Declaration of transactions on treasury shares(period from April 20 to 24, 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025...
► Artikel lesen
NEURONES Aktie jetzt für 0€ handeln
20.04.NEURONES: Declaration of transactions on treasury shares (April 13 to 17, 2026)283Nanterre, April 20, 2026 Declaration of transactions on treasury shares(period from April 13 to 17, 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025...
► Artikel lesen
13.04.NEURONES: Declaration of transactions on treasury shares (April 6 to 10, 2026)280Nanterre, April 13, 2026 Declaration of transactions on treasury shares(period from April 6 to 10, 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025...
► Artikel lesen
07.04.NEURONES: Declaration of transactions on treasury shares (March 30 to April 3, 2026)348Nanterre, April 7, 2026 Declaration of transactions on treasury shares(period from March 30 to April 3, 2026) As part of the share buyback program authorized by the General Meeting of June 5...
► Artikel lesen
30.03.NEURONES: Declaration of transactions on treasury shares (March 23 to 27, 2026)212Nanterre, March 30, 2026 Declaration of transactions on treasury shares(period from 23 to 27 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025...
► Artikel lesen
23.03.NEURONES: Declaration of transactions on treasury shares (March 16 to 20, 2026)320Nanterre, March 23, 2026 Declaration of transactions on treasury shares(period from 16 to 20 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025...
► Artikel lesen
16.03.NEURONES: Declaration of transactions on treasury shares (March 9 to 13, 2026)297Nanterre, March 16, 2026 Declaration of transactions on treasury shares(period from 9 to 13 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025...
► Artikel lesen
11.03.NEURONES: Net profit, Group share stable in 2025367PRESS INFORMATIONHeading: 2025 annual results Nanterre, March 11, 2026 (after trading) Net profit, Group share stable in 2025 Financial statements at December 31 (1)20242025Revenues810.4857.2Business...
► Artikel lesen
11.02.NEURONES: 5.1% organic growth in 2025357PRESS INFORMATIONHeading: 2025 annual revenues Nanterre, February 11, 2026 (after trading) 5.1% organic growth in 2025 (being audited, in € millions)20242025Growthof which organic4rd...
► Artikel lesen
05.11.25NEURONES: Organic growth up 5.1% in 3rd quarter 2025248PRESS INFORMATIONHeading: 3rd quarter 2025 revenues Nanterre, November 5, 2025 (after trading) Organic growth up 5.1% in 3rd quarter 2025 (not audited, in millions of euros)20242025growthof...
► Artikel lesen
21.10.25NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025)361Nanterre, October 21, 2025 Declaration of transactions on treasury shares(period from 13 to 17 October 2025) As part of the share buyback program authorized by the General Meeting of June 5...
► Artikel lesen
10.09.25NEURONES: Neurones: 6.3% net profit in 1st half 2025447PRESS INFORMATIONHeading: 1st half 2025 results Nanterre, September 10, 2025 (after trading) 6.3% net profit in 1st half 2025 (in millions of euros)H1 20242024H1 2025 *Revenues402.4810.4424.3Business...
► Artikel lesen
10.09.25Neurones: 6.3% net profit in 1st half 2025314PRESS INFORMATIONHeading: 1st half 2025 results Nanterre, September 10, 2025 (after trading) 6.3% net profit in 1st half 2025 (in millions of euros)H1 20242024H1 2025 *Revenues402.4810.4424.3Business...
► Artikel lesen
06.08.25NEURONES: Organic growth up 5.3% in 2nd quarter 2025429PRESS INFORMATION Nanterre, August 6, 2025 (after trading)Heading: 1st half 2025 revenues Organic growth up 5.3% in 2nd quarter 2025 Revenues (millions of euros)20242025Growthof which...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1